(Q47840842)

6 February 2018

title

Cardiac effects of halofantrine in children suffering from acute uncomplicated falciparum malaria (English)

1 reference

6 February 2018

main subject

malaria

0 references

Plasmodium falciparum

0 references

1 reference

1

Sowunmi A

1 reference

6 February 2018

3

Oduola AM

1 reference

6 February 2018

author name string

Falade CO

2

1 reference

6 February 2018

Ogundahunsi OA

4

1 reference

6 February 2018

Fehintola FA

5

1 reference

6 February 2018

Gbotosho GO

6

1 reference

6 February 2018

Larcier P

7

1 reference

6 February 2018

Salako LA

8

1 reference

6 February 2018

publication date

1 July 1998

1 reference

6 February 2018

Transactions of the Royal Society of Tropical Medicine and Hygiene

published in

1 reference

6 February 2018

volume

92

1 reference

6 February 2018

issue

4

1 reference

6 February 2018

page(s)

446-448

1 reference

6 February 2018

Prolonged QT interval with halofantrine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2991086-0

7 January 2021

Comparative efficacy of halofantrine, chloroquine and sulfadoxine-pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2991086-0

7 January 2021

Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2991086-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2991086-0

1 reference

7 January 2021

Cardiac effect of halofantrine

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2991086-0

7 January 2021

Cardiac complications of halofantrine: a prospective study of 20 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2991086-0

7 January 2021

Cardiac effects of antimalarial treatment with halofantrine

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2991086-0

7 January 2021

Evaluation of the clinical efficacy and safety of halofantrine in falciparum malaria in Ibadan, Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2991086-0

7 January 2021

Prolongation of the QTc interval in African children treated for falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2991086-0

7 January 2021

Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2991086-0

7 January 2021

Efficacy of multiple-dose halofantrine in treatment of chloroquine-resistant falciparum malaria in children in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2991086-0

7 January 2021

Quinine and quinidine: a comparison of EKG effects during the treatment of malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2991086-0

7 January 2021

Clinical trials with halofantrine hydrochloride in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2898%2991086-0

7 January 2021

10.1016/S0035-9203(98)91086-0

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018